KMT2A and leukemia: In most leukemias, residual core complex including MLL-C would be expected to be present and retain its histone methyltransferase activity, either from expression of the reciprocal fusion (although this probably happens only in a minority of patients) or from the second, non-rearranged MLL1 allele.